Enanta Pharmaceuticals SG&A Expense (Quarterly) Trends

Enanta Pharmaceuticals Inc (ENTA)

12.04 -1.02 (-7.81%) USD | NASDAQ | May 20, 10:19

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2011. Upgrade now.

Date	Value
March 31, 2024	14.24M
December 31, 2023	16.52M
September 30, 2023	13.80M
June 30, 2023	12.62M
March 31, 2023	13.78M
December 31, 2022	12.70M
September 30, 2022	12.57M
June 30, 2022	12.93M
March 31, 2022	10.48M
December 31, 2021	9.508M
September 30, 2021	8.356M
June 30, 2021	8.477M
March 31, 2021	8.326M
December 31, 2020	7.377M
September 30, 2020	6.728M
June 30, 2020	6.823M
March 31, 2020	6.884M
December 31, 2019	6.921M
September 30, 2019	6.163M
June 30, 2019	6.151M
March 31, 2019	6.78M
December 31, 2018	7.152M
September 30, 2018	5.83M
June 30, 2018	6.135M
March 31, 2018	5.706M

Date	Value
December 31, 2017	5.77M
September 30, 2017	5.118M
June 30, 2017	5.233M
March 31, 2017	5.461M
December 31, 2016	4.937M
September 30, 2016	4.44M
June 30, 2016	4.282M
March 31, 2016	4.426M
December 31, 2015	3.818M
September 30, 2015	3.693M
June 30, 2015	3.643M
March 31, 2015	3.438M
December 31, 2014	2.769M
September 30, 2014	2.761M
June 30, 2014	2.603M
March 31, 2014	2.565M
December 31, 2013	2.087M
September 30, 2013	1.75M
June 30, 2013	1.788M
March 31, 2013	1.493M
December 31, 2012	1.152M
September 30, 2012	1.699M
June 30, 2012	1.145M
March 31, 2012	1.207M
December 31, 2011	1.251M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

6.151M

Minimum

Jun 2019

16.52M

Maximum

Dec 2023

10.07M

Average

8.992M

Median

SG&A Expense (Quarterly) Benchmarks